Skip to content
Screener

Repligen RGEN Q1 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$194.3MBeat by $2.2M
EPS$0.48Beat by $0.10
Revenue estimate$192.1M
EPS estimate$0.38

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$206.8M
EPS estimate$0.46

Financials

Q1 2026

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$6.64B-7.1%
Enterprise value$6.74B+2.1%
P/E129.1×—

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Segments

By product

See full
Royalty$44.0K+25.7%

FAQ

When did Repligen report Q1 2026 earnings?
Repligen (RGEN) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Repligen's Q1 2026 revenue and EPS?
Repligen reported revenue of $194.3M and eps of $0.48 for Q1 2026.
Did Repligen beat estimates in Q1 2026?
Revenue beat the consensus estimate of $192.1M by $2.2M. EPS beat the consensus estimate of $0.38 by $0.10.
How did Repligen's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 14.8% from $169.2M a year earlier and eps grew 23.1% from $0.39.
Where can I find Repligen's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-205011) and the 10-Q periodic report (0001193125-26-208954) directly on SEC EDGAR. The filing index links above go to sec.gov.